Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Characterization of a recombinant outer surface protein A (OspA) vaccine against Lyme disease.

Huebner RC, Gray MA, Holt J, Wu XD, Mays JP.

Dev Biol (Basel). 2000;103:163-73.

PMID:
11214234
2.

Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.

De BK, Sampson JS, Ades EW, Huebner RC, Jue DL, Johnson SE, Espina M, Stinson AR, Briles DE, Carlone GM.

Vaccine. 2000 Mar 6;18(17):1811-21.

PMID:
10699329
3.

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.

Briles DE, Ades E, Paton JC, Sampson JS, Carlone GM, Huebner RC, Virolainen A, Swiatlo E, Hollingshead SK.

Infect Immun. 2000 Feb;68(2):796-800.

4.

Baculovirus expression, purification and evaluation of recombinant pneumococcal surface adhesin A of Streptococcus pneumoniae.

De BK, Sampson JS, Ades EW, Johnson SE, Stinson AR, Crook J, Tharpe JA, Huebner RC, Carlone GM.

Pathobiology. 1999 May-Jun;67(3):115-22.

PMID:
10394131
5.

Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.

Luke CJ, Huebner RC, Kasmiersky V, Barbour AG.

Vaccine. 1997 Apr-May;15(6-7):739-46.

PMID:
9178476
6.

Carboxyl-terminal determinants of Abelson protein important for lymphoma induction.

Parmar K, Huebner RC, Rosenberg N.

J Virol. 1991 Dec;65(12):6478-85.

Supplemental Content

Loading ...
Support Center